Highlights
- Screening at 36 weeks’ gestation effectively identifies women at high risk for developing term pre-eclampsia.
- Scheduled birth at 37–38 weeks for women with a risk ≥1 in 50 reduces the incidence of pre-eclampsia by 30%.
- The intervention does not increase the rates of emergency cesarean sections or neonatal intensive care unit (NICU) admissions.
- This risk-stratified approach provides a viable solution for preventing term pre-eclampsia, where aspirin has historically shown limited efficacy.
The Challenge of Term Pre-eclampsia
